US FDA gives second approval to Eli Lilly's drug for type of blood cancer

Posted on:
Key Points

Dec 1 (Reuters) - Eli Lilly (LLY.N) said on Friday the U.S. Food and Drug Administration (FDA) gave a second approval for its drug Jaypirca, which is used to treat a form of blood cancer...

The company said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of cancer in which the bone marrow makes too many of certain white blood cells...

Jaypirca was first given accelerated approval by the FDA on Jan. 27 for the treatment of mantle cell lymphoma (MCL), a rare type of blood cancer that starts in white blood cells and spreads to other parts of the body...

You might be interested in

Eli Lilly's cancer drug gets second approval from US FDA

02, Dec, 23

Eli Lilly's drug Jaypirca has received a second approval from the US FDA for the treatment of chronic lymphocytic leukemia (CLL), adding to its previous approval for mantle cell lymphoma (MCL).

US regulators inspect Dr Reddy's, other Indian pharma majors

05, Dec, 23

The U.S. Food and Drug Administration is inspecting Dr Reddy's (REDY.NS) research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.

Lilly's bowel disease drug gets US FDA nod for treatment in adults

27, Oct, 23

Eli Lilly and Co (LLY.N) said on Thursday that the U.S. health regulator had approved its drug for treating adults with moderate-to-severe active ulcerative colitis, a type of chronic inflammatory bowel disease.

US FDA asks to not purchase certain eye drops due to infection risk

28, Oct, 23

The U.S. Food and Drug Administration on Friday issued a warning to consumers to not purchase or use certain eye drops from several major brands due to the risk of eye infection.

GSK says blood cancer drug meets primary goal in late-stage trial

27, Nov, 23

British drugmaker GSK (GSK.L) said on Monday its blood cancer drug Blenrep, when used as a second-line treatment in patients with myeloma, met its primary goal of progression-free survival in a late-stage trial.

US FDA approves Otsuka's blood pressure treatment device for use

08, Nov, 23

The U.S. Food and Drug Administration (FDA) approved the use of a device made by an Otsuka Holdings (4578.T) unit in a type of surgery to treat high blood pressure, the company said on Wednesday.

Blood cancer in pregnancy: Tips on balancing treatment and motherhood

05, Jan, 24

Managing blood cancer during pregnancy should be individualised to the specific circumstances. Here are expert tips on balancing treatment and motherhood | Health